Clinical trial
Efficacy Assessment of Transcranial Direct Current STIMulation (tDCS) in Reducing Pain in PALliative Cancer Patients.
NCT04683172 is registered in ClinicalTrials.gov with Elsan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Assessment of Transcranial Direct Current STIMulation (tDCS) in Reducing Pain in PALliative Cancer Patients.
- Lead sponsor
- Elsan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 15, 2021
- Completion date
- June 15, 2024
- Enrollment
- 70 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer pain, refractory pain